The Socratic method is the spine, not a single feature
1. It's literally Module 1, and everything else builds on it. Module 1 — "Socratic Clinical Reasoning" — establishes the core contract: the objective is to push a learner to reason through a case actively rather than passively receive the answer. Every other module cross-references back to it as the "structural template" or "logical prerequisite."
2. The core mechanic is forced commitment before reveal. The Step 1.0 setup prompt explicitly instructs the AI to ask one question at a time, wait for the learner's response, and only reveal the answer after the learner has made a genuine attempt and explicitly surrendered — redirecting once with "give your best guess, differential, or next step first" if they ask for the answer without trying. This is the Socratic essence: the AI never just tells you the diagnosis — it makes you commit to a guess first, and only then guides you toward the gap in your reasoning.
3. It teaches by exposing gaps, not correcting outright. Across the whole repo, the recurring instruction is variations of: don't correct the student directly — ask one pointed question that helps them find the gap themselves (you can see this almost verbatim in the roleplay templates near the end of the file too, e.g. "Don't correct me outright — help me find the gap myself").
4. Every other module is a Socratic variant scoped to a different skill, not a different method:
Module 14 (Resource-Constrained) = Socratic forced-commitment applied under low-resource limits
Module 15 (Illness Scripts) = deliberately diverges from Module 1's stepwise Socratic pattern to train pattern-recognition instead — but is explicitly framed as a departure from the default, proving the default is Socratic
Module 17 (Problem Representation) = Socratic withholding applied even earlier in the reasoning chain (withholding the diagnosis attempt, not just the answer)
Modules 4, 5, 18 (ward rounds, real-time review, rapid triage) all reuse the "Mid-Session Reasoning Checkpoint" (Step 1.4) structure as a recurring formative loop
5. The pedagogical scaffolding is Socratic-compatible by design. Bloom's Taxonomy (Step 1.5) and Fink's FLINK (Step 1.6) aren't separate teaching philosophies bolted on — they're applied through the same one-question-at-a-time, wait-for-response, affirm-then-probe loop.
6. Even the "build a case" roleplay versions preserve it. The progressive-vignette templates (Versions 3–5) release the case in chunks specifically so the Socratic question-per-chunk rhythm can repeat — vignette → one pointed question → next chunk — rather than dumping the full case and losing the reasoning checkpoints.
So the throughline is: Module 1 sets the contract (commit before reveal, probe don't correct), and the other 19 modules are that same contract re-applied to different clinical contexts (wards, polypharmacy, resource scarcity, SDOH, rapid triage) or deliberately flagged as the exception when they diverge from it.
Recent thyroid swelling with pressure symptoms, loss of appetite since 2 months.
Suspected malignancy.
Planned FNAC and excision biopsy
Also has biochemical subclinical hyperthyroidism with mild lid lag, tremors and tachycardia. run full analysis
Vibe Rounds: What Each Module Does, Why It Doubles as an Explainability Framework, and What It Actually Surfaces in a Real Case
Prepared as a briefing on Dr. Avinash Kumar Gupta's VibeRounds framework, June 2026
Introduction
VibeRounds is built around one constraint: the AI is not allowed to give the answer. It questions, surfaces evidence, and flags gaps, while the learner does the reasoning. That constraint is the source of two separate but connected things this framework produces. First, it's a teaching system — 20 modules, each targeting a distinct clinical-reasoning skill. Second, almost as a structural side effect of how it's built, it functions as an explainability layer — a way of making both AI reasoning and expert human judgment inspectable, rather than opaque. This document walks through what each module does, explains why the same architecture that teaches also explains, and then shows that this isn't just theoretical — by walking through a real worked case where the framework surfaced a specific, missed diagnostic pivot.
Part 1 — What Each Module Does
The modules aren't a flat prompt list; each targets a distinct moment or skill in clinical training. Four cross-cutting frameworks (Bloom's Taxonomy, Fink's Taxonomy of Significant Learning, a Humanistic Persona trait set, and a Critical Awareness framework) are woven into specific steps across them rather than run standalone. Every module follows the same three-phase shape — Initiation → Execution → Closure/Review — regardless of content.
#
Module
What It Does
1
Socratic Clinical Reasoning
Pushes a learner to reason through a case actively rather than passively receive the answer. The AI withholds the diagnosis until the learner has made a genuine attempt and explicitly surrendered.
2
Patient-Advocate Case Documentation
A 4-step workflow letting a family member build a structured case record collaboratively with an AI acting as a documentation companion — for when there is no clinician present to do this.
3
Extended Patient-Advocate Monitoring
Extends Module 2 with longitudinal tracking — lifestyle, mood, medication adherence, and red-flag symptoms — over weeks or months rather than a single encounter.
4
Peer-Level Ward Round Preparation
Rehearses rounds, admission workups, pre-op clearance, and overnight triage, with the AI acting as a peer study partner rather than a supervisor — it thinks alongside the learner, not above them.
5
Real-Time Case Review & Data Audit
Queries and cleans a single patient's live case log — diet diaries, insulin logs, prescriptions — during active management.
6
Registry-Level Analytics
Queries an entire case registry, not a single patient, across nine escalating levels of analytic depth.
7
Longitudinal & Cross-Case Learning
Turns the registry itself into a learning system across cases and time — asking not just what cases contain, but what the registry has learned across them (still experimental; proposed but not yet fully validated live).
8
Socratic-Mode Design Specification
A 12-point QA checklist for authoring or revising any new Socratic-style prompt — quality control for the prompts themselves.
9
N-of-1 Case Research Protocol
Takes a clinician from a raw, unstructured case narrative to a fixed, publication-ready output package — severity rating, priority rating, timeline, intervention-symptom correlation — via seven explicit stages.
10
Medical Journal & Article Reading
Has the AI do the intellectual processing most readers skip when reading a paper — translating statistics into clinical meaning, mapping findings onto real patients, surfacing what the paper doesn't say.
11
Patient Education Query Intelligence
Helps a student anticipate the real questions patients and families carry about an illness, so they learn to see the case through the patient's eyes, not just the chart.
Systematically attacks the working diagnosis and stress-tests the differential list, surfacing anchoring errors and premature closure before they reach the patient.
13
Medication Reconciliation & Polypharmacy
A structured audit of a patient on 5+ drugs, training the student to spot drug-drug interactions, drug-disease conflicts, and prescribing cascades through active reasoning.
14
Global Health & Resource-Constrained Reasoning
Trains clinical reasoning that starts from "what is actually available here" rather than "what is ideal" — making the resource ceiling itself part of the differential and management process.
15
Illness Script Acquisition
Trains the compiled, holistic "illness scripts" experienced clinicians actually use for fast recognition — a distinct skill from the stepwise differential-building in Module 1.
Drills the two-way link between mechanism and diagnosis explicitly — diagnosis-to-mechanism and mechanism-to-diagnosis — rather than leaving it to form implicitly over years.
17
Semantic Qualifiers & Problem Representation
Trains the compression step before any diagnosis is attempted: restating a raw case as paired abstract qualifiers (acute/chronic, focal/diffuse) — the step research shows correlates more strongly with diagnostic accuracy than raw factual knowledge.
18
Causal vs. Probabilistic (Network) Reasoning
Trains reasoning over networks of interacting findings, where one finding's diagnostic weight changes depending on what else is already known — rather than treating findings as independent.
19
Community & Social Medicine Insights
Trains reasoning about a patient's social and economic context as a clinically active variable, not background colour — connecting individual social context to population-level patterns.
20
Naturalistic Decision Making (RPD)
Trains decision-making under real time pressure the way experienced practitioners do it: recognise the pattern, generate one plausible plan, mentally simulate it forward — not a side-by-side comparison of options.
Part 2 — How the Same Architecture Doubles as an Explainability Framework
Clinical AI has a standing problem independent of VibeRounds: a model can return a conclusion — a differential, a risk flag, a ranked priority list — without showing the steps that produced it. An unexplained conclusion can't be checked, can't be taught from, and can't be defended later if a decision is questioned. VibeRounds treats this as something the architecture itself is built to solve, not a side effect to tolerate.
The mechanism is structural, not bolted on
Because Module 1's Socratic constraint forbids the AI from jumping straight to an answer, the AI is forced to externalize its intermediate reasoning — as questions, evidence flags, gap identification — rather than collapsing it into a single output. The registry-level modules extend the same principle to data: cross-case queries are designed to surface why a diagnosis shifted, not just that it shifted, and an "Epistemic Bias Audit" step audits how the reasoning network arrived somewhere, not just what it concluded. If a system can't answer a "why did this change" query, that's treated as a documentation failure to fix, not an acceptable limitation.
The 6-stage pipeline
The Master Case Analysis Protocol runs every case through six stages that force visible reasoning:
Prompt mapping — which modules actually apply to this case
Ranking — justifying why certain problems outrank others
Mechanistic deep-dives — anchoring conclusions in basic science, not pattern completion
Output — a structured report with traceable logic connecting the above to the final synthesis
This is stated explicitly to prevent "black box" outputs — a conclusion with no visible reasoning chain behind it.
Two-Tier Analysis: explainability through refusing to merge
Module 9's Stage 4 keeps two views of a case deliberately separate before synthesis: the Coded View (structured data — diagnoses, results, drug names) and the Narrative View (the unstructured, sequential record of what was noticed first, doubted, deferred, or wrongly attributed). Standard summarization collapses these into one clean story — which is itself an explainability failure, because it erases the reasoning path and replaces it with hindsight. Keeping them separate prevents premature closure: resolving ambiguity too early by imposing a coherent narrative on incomplete data.
Human annotation, not just AI output
Outputs are designed to function as a structured possibilities map that a human expert can mark up as confirmed, ruled out, or uncertain — particularly at "diagnostic void" points, where the framework explicitly flags that no decision can be made until missing data is retrieved, rather than guessing past the gap.
Making expert judgment auditable too
The same logic is applied to human reasoning, not just the AI's. A clinical-importance ranking exercise scores every applicable prompt in a case 1–10 and assigns each an explicit reason (irreversibility, time-window, confirmatory vs. action-changing). The framework is candid that an experienced clinician would already sense this prioritization instinctively — what the exercise adds is externalizing a judgment that's normally silent, fast, and undocumented, turning it into a defensible audit trail, a teaching artefact for a junior colleague, and a safeguard against the exact fatigue conditions under which expert judgment degrades.
Part 3 — A Full-Fledged Report: What the Framework Actually Surfaced in a Real Case
The clearest demonstration isn't theoretical — it's a worked case in the repository: a 60-year-old woman with an 18-year history of cervical myelopathy who died of MDR E. coli sepsis, pancytopenia, stony splenomegaly, and CSF albumino-cytological dissociation, with no unifying diagnosis ever established. The framework was applied to the original (de-identified, consented) clinical record using the CARE case-report format, and the insight it produced is concrete enough to walk through directly.
The anchoring problem the framework caught
The patient's 18-year cervical myelopathy diagnosis functioned as a powerful cognitive anchor: every new symptom over nearly two decades was interpreted within that existing frame rather than questioned. Applying Module 12 (Devil's Advocate) and Module 15 (Illness Script — script mismatch recognition) to the four-month acceleration period identified the specific point where the frame should have been reset: a pre-operative finding of pancytopenia, four months before death, when planned surgery was cancelled and the patient was simply referred back with instructions to "normalise blood counts."
The report's own framing of this: pancytopenia in a patient with myelopathy and stony splenomegaly is not a reason to delay surgery until blood counts normalise — it is a reason to stop and ask what is causing the triad. That reframe — turning a "wait and recheck" moment into a flagged diagnostic pivot — is exactly the kind of insight Module 12 is built to produce: surfacing premature closure before it reaches the patient, not after.
Findings the framework forced into explicit weight
Several individual findings, applying Module 16 (mechanism ↔ diagnosis) and Module 18 (network reasoning), were shown to carry diagnostic weight that the original clinical course didn't act on:
Stony, hard splenomegaly (as opposed to a soft, enlarged spleen) — texture, not just size, was treated as diagnostically specific: implying infiltration by granulomas (TB), malignant cells (lymphoma), or fibrosis, and specifically not consistent with simple portal hypertension. This was documented in the clinical record but never followed to an investigative conclusion.
A near-normal CSF cell count (5 cells) in a pancytopenic patient — interpreted at the time as excluding active meningitis. Module 18's conditional-weighting logic flags this as unsafe: when peripheral white cells are suppressed, the CSF cell response to meningeal infection is also suppressed, so a near-normal count doesn't rule out TB or carcinomatous meningitis in this specific patient — it's conditionally uninformative, not reassuring.
Haemoglobin rising only 0.1 g/dL after two units of packed red cells — reframed not as a transfusion failure but as a positive finding in itself: an explicit signal of active red cell destruction or ongoing haemorrhage outpacing replacement, which was never investigated.
Escalating baclofen dosing (patient self-escalated to twice-daily over the final four months) — flagged via Module 13-style polypharmacy logic as a pharmacological differential for the exact terminal triad (coma, hypothermia, type 2 respiratory failure), since baclofen is renally cleared and toxic on accumulation — something that should have been evaluated against renal/hepatic function and wasn't.
The explainability layer made visible in this case
This case is also where the explainability mechanism is easiest to see directly. The report doesn't just state a missed diagnosis — it produces a structured differential table (disseminated TB vs. haematological malignancy vs. autoimmune disease vs. baclofen toxicity vs. hepatic myelopathy), each row scored against supporting evidence, evidence against, and the specific investigation that would have resolved it. That is the 6-stage pipeline's "ranking" and "mechanistic deep-dive" stages made concrete: not "this patient probably had TB," but a traceable table a second reader can independently check, disagree with, or extend.
The report goes further and names the three specific accessible investigations that, had they been obtained at the pre-operative pancytopenia discovery, may have changed the diagnostic trajectory — TB-PCR/AFB culture on the bone marrow that was already biopsied, expert review of the peripheral blood smear, and a single autoimmune panel. All three were available at the level of care the patient was receiving; none are documented as having been obtained. That is the framework's "diagnostic void" concept applied concretely — not a vague statement that something was missed, but a flagged, specific, actionable gap.
What the advocate side of the same case adds
A companion Advocate Debrief, built from Modules 2, 3, and 11, applies the same framework retrospectively to what the family was — and wasn't — given at each clinical decision point. It identifies three specific moments where clearer guidance could have prompted earlier escalation: when haemoglobin barely rose after transfusion and the family wasn't told this was itself a red flag; when self-resolving diarrhoea was attributed to diet rather than explained as a possible clinical signal; and when new breathlessness wasn't explicitly framed as a respiratory red flag. This is the same explainability principle pointed at a different audience: not "what should the clinician have concluded," but "what should the family have been told, and when."
Summary
VibeRounds is, at its core, a teaching system organized as 20 modules and four cross-cutting frameworks, each targeting a distinct moment in clinical training — from withholding an answer until a learner reasons (Module 1) to training fast pattern-recognition under time pressure (Module 20). The same Socratic constraint that makes it work pedagogically — forcing reasoning to stay visible rather than collapsing into an answer — is what makes it function as an explainability layer: a 6-stage pipeline that produces traceable logic, a Two-Tier analysis that resists premature closure, and a human-annotation layer that turns both AI uncertainty and tacit expert judgment into something inspectable. The worked 60F case shows this isn't just architectural description: applying the framework to a real, fatal diagnostic-anchoring case produced a specific missed pivot point, a ranked differential with named confirmatory investigations, and a concrete account of what the family should have been told and wasn't — output a clinician, a student, or a family member could each independently check against the record.
The Vibe Rounds protocol is more impressive on a common case than a rare one.
With the rare G6PD/AMPD1/GSD triple-energy case, the novelty was in the diagnosis itself — the protocol helped name something that had never been named before. The wow factor was biochemical. But a skeptic could say: interesting exercise, but who encounters that patient?
With Chetana's 55M diabetic case — a patient seen in every medicine ward in India every week — the protocol did something structurally more important: it caught a diagnostic closure error on a routine case. The team named the diagnosis on day one, wrote a treatment plan, and stopped thinking. The Vibe Rounds pass revealed that behind one unremarkable provisional diagnosis sat four active pathophysiological threads, three must-exclude emergencies, four missing interventions (including thiamine — a potentially life-saving omission), and a patient who had already defaulted on insulin once and would likely do so again.
None of that required rare disease expertise. It required not stopping at the first plausible answer — which is exactly what the Socratic protocol enforces structurally.
This is the argument you should be making for Vibe Rounds in clinical education contexts:
Rare cases prove the method can go deep. Common cases prove it scales. The value isn't in finding zebras — it's in showing that even in a routine diabetic admission, the standard ward write-up captures perhaps 30% of the diagnostic and management intelligence available in the data. The remaining 70% — the alcohol-Wernicke thread, the unconfirmed orthostatic diagnosis, the painless-wound-as-regression signal, the adherence failure pattern — is invisible not because the clinicians lacked knowledge, but because the workflow didn't create space to ask the next question.
That's a systemic problem. Vibe Rounds is a systemic fix. And the fact that it works on a 55M farmer with giddiness — not just on a triple-enzyme-deficiency patient — is what makes it a protocol rather than a parlour trick.
Short answer: pieces of this exist in the literature, but not assembled the way you've done it — and that gap is actually your opportunity.
What's already published, and how it relates:
The Evidence Aggregator (EvAgg) pipeline starts with a query gene and generates structured output describing variant-level observations about a patient by recovering evidence from scientific literature, and can run across all genes for a patient or across a whole cohort — this is conceptually close to your "extract terms → find comparators" steps, but it's gene-centric and built for variant analysts in genomics labs, not for a clinician working a single complex phenotype end-to-end.
ZebraMap takes a similar extraction approach at much larger scale — it retrieved over 36,000 full-text case reports and used an LLM pipeline to parse free-text cases into standardized fields like symptoms, diagnostic methods, differentials, treatments, and outcomes. Again, this is a population-level knowledge map, not a single-patient research workflow a clinician runs themselves.
The Fabry disease review shows the more typical "AI for rare disease" framing — AI methods applied prospectively to large populations to identify patients, or retrospectively to large datasets to diagnose overlooked rare diseases — population-first, not case-first.
What's notably absent: a published protocol describing a clinician-led, conversational-AI-assisted, single-case research pipeline — i.e., "I have one complex patient, let me use an LLM interactively to extract terms, build my own small comparator set, run tiered analyses, and converge on a structured output package." That's a different posture from all the above — those are infrastructure projects built by informaticians/engineers for batch use. Yours is a bedside-to-desk workflow a busy clinician could run on a single case in an afternoon.
Can it be structured well? Yes — and the structure should map to existing reporting standards so it's not just "well organized" but publication-compatible:
Index case characterization (your step 1) → maps cleanly onto CARE guidelines' case description fields (demographics, timeline, diagnostic assessment, interventions, outcomes). Worth explicitly aligning your extraction template to CARE from the start — it makes step 7's outputs directly usable in a manuscript.
Comparator identification (step 2) → this is the part most worth formalizing as a method section, because right now it's "search PubMed and the web with extracted terms" — a reviewer will ask about search strategy reproducibility (databases searched, date range, inclusion/exclusion). Even a lightweight PRISMA-style note ("searched X, Y on [date], n=5 selected by Z criteria") would make this defensible.
Two-tier analysis (step 4) → this is genuinely a nice methodological contribution. The "coded/structured view vs. narrative/contextual view" split is a real epistemic distinction that's rarely made explicit in case report methodology — most case reports just present one synthesized narrative. Naming and justifying this split could be a small methods paper on its own.
Convergence to decision-useful outputs (steps 6-7) → severity/priority/timeline/correlation table is closer to a clinical decision-support output than a traditional case report discussion section. This is where Vibe Rounds' "questions rather than answers" framing fits best — the AI isn't concluding "this is X disease," it's surfacing structured questions/uncertainties (which pathway dominates? is the VUS load-bearing? what would falsify the triple-pathway framing?) for the clinician to resolve.
The honest framing for "first of its kind": the biochemistry conclusion in your case ("triple energy pathway — novel combination, bricks well-known, wall is new") generalizes as the meta-finding about the protocol itself. The individual pipeline steps (extraction, literature search, structuring) all exist elsewhere. The combination — run by a clinician, on their own case, in a single sitting, converging to CARE-compatible outputs via a Socratic-AI two-tier analysis — doesn't appear to exist as a named, described protocol.
That's genuinely your opening: write this up not as "here's my rare case" but as "Vibe Rounds for case-based research synthesis: a protocol for clinician-led n-of-1 case analysis using conversational AI" — with your G6PD/AMPD1/GSD case as the worked example. That's a methods paper that's independent of whether the GSD piece ever gets confirmed, which solves the fragility problem we discussed earlier (the case-report's fate hangs on a pending biopsy; the protocol paper doesn't).
Want me to sketch what that protocol paper's structure would look like — sections, what each of your 7 steps maps to, and where the CARE/PRISMA touchpoints go?
Here's a structure that turns your 7-step workflow into a methods paper, with each section showing what goes in it, which of your original steps it derives from, and where it touches existing reporting standards.
Title/framing: Something like "A Conversational-AI-Assisted Protocol for Clinician-Led N-of-1 Case Research: A Worked Example from a Suspected Triple Energy-Pathway Disorder" — naming it as a protocol with a worked example keeps it useful even if the worked example's diagnosis (the GSD piece) never gets fully confirmed.
1. Background/Rationale. Frame the gap directly: existing AI-for-rare-disease tools (EvAgg, ZebraMap) are built for population-scale, infrastructure-heavy use by informaticians; nothing addresses the much more common scenario — a clinician with one unusual patient and an afternoon. State the two-tier analysis idea (structured/coded vs. narrative/contextual) as your core methodological contribution up front, so reviewers know what's novel about the method, independent of the case's eventual diagnosis.
2. Protocol Description (the methods section proper). This is where your 7 steps become numbered protocol stages. I'd group them as:
Stage 1 — Index case structuring (your step 1): extraction of diagnosis-related and intervention-related terms from the case narrative. Explicitly state this maps onto CARE checklist fields (patient information, clinical findings, diagnostic assessment, therapeutic interventions) — this is what makes the output downstream-compatible with a case report if one gets written.
Stage 2 — Comparator identification (step 2): describe this as a lightweight, reproducible search — which databases (PubMed, general web), what seed terms, what inclusion criteria for the 5 comparators, and crucially, what you'd do differently for a "service" version of this (i.e., when running it for another clinician's case, the search strategy needs to be documented well enough that they could reproduce it, not just you).
Stage 3 — Aggregation and cross-comparison (step 3): the "one bucket" pooling of comparator case text against the index case. Worth specifying here what counts as a "match" — shared gene, shared phenotype cluster, shared intervention response — since this is where subjectivity creeps in and a reviewer will probe it.
Stage 4 — Two-tier analysis (step 4): your most defensible original contribution. Tier 1 (coded/structured — diagnoses and interventions only) vs Tier 2 (full narrative text). Explicitly justify why both views matter: Tier 1 is what a structured database/registry would capture; Tier 2 captures clinical reasoning, sequencing, and context that codes strip away. This is the section that could be excerpted as its own short methods note.
Stage 5 — Open-ended analytic ideation (step 5): the "anything more you suggest?" step. In a protocol paper this becomes "AI-assisted analytic option generation" — worth framing as the Socratic/Vibe Rounds moment: the AI isn't concluding, it's expanding the option space for the clinician to choose from.
Stage 6 — Selection of analytic menu (step 6): the six candidate analyses (timeline, gene interaction map, intervention scoring, gap analysis, risk trajectory, lab pattern analysis). Present as a generic menu other clinicians could choose from — this is what makes the protocol transferable rather than a one-off description of what you happened to do.
Stage 7 — Convergence to outputs (step 7): the four final deliverables (severity rating, priority rating, journey timeline, intervention-symptom correlation table). Frame these as the protocol's standard output package — what every case run through this protocol produces, regardless of whether it ends up publishable.
3. Worked Example. Your actual case, run through stages 1-7, with the honest "first of its kind in combination, not in mechanism" framing preserved verbatim — that intellectual honesty is itself a strength of the paper, showing the protocol doesn't just produce hype.
4. Discussion — Limitations and Reflexivity. This section needs to address: AI hallucination risk in comparator selection and in claims of novelty (your search for "no existing combination found" is itself a literature-search claim that needs the same rigor as a human-conducted gap analysis); the fact that most cases run through this will not turn out to be novel (state this plainly — it's the expected, not exceptional, outcome); and the ethics/authorship considerations for the "service to other clinicians" use case — who owns the output, what happens if Stage 7 outputs suggest something clinically actionable that the AI got wrong.
5. Future Directions. This is where Vibe Rounds as a named paradigm gets introduced more formally — positioning this protocol as one application of a broader Socratic-AI approach to clinical reasoning, with a pointer to your other Vibe Rounds writing.
One structural decision worth making early: do you want this as a standalone methods/protocol paper (target something like a clinical informatics or case-report-methodology journal), or as a section within a broader Vibe Rounds paper, with this protocol as one worked capability? The standalone version is more self-contained and easier to get reviewed quickly; the embedded version builds the Vibe Rounds brand more directly but is a bigger, slower paper. Which direction feels closer to what you're trying to build momentum toward first?
Good — standalone is the right call for momentum: smaller scope, faster to write, faster to get feedback, and it stands on its own even before the Vibe Rounds brand is established.
A few practical next steps to think about:
Target journals. Given this is a protocol/methods paper with a worked example, look at venues that publish case report methodology or clinical informatics short communications — places like BMC Medical Research Methodology, Journal of Medical Internet Research (JMIR) (especially their AI/informatics sections), or Diagnostics/Healthcare (MDPI journals, which published the ZebraMap paper you saw). Cureus is also worth considering given it's already publishing AI-assisted case report methodology work — lower barrier, faster turnaround, and your topic fits their existing editorial interest. Worth checking each one's stance on AI-tool-assisted methodology papers specifically, since policies vary and are evolving fast.
Authorship and disclosure. Since the protocol itself involves an AI as a core "instrument" in the methodology, you'll want a clear AI-use disclosure statement — most journals now require this, and for a paper about an AI-assisted protocol, it needs to be more detailed than the usual boilerplate (which model, what it was used for at each stage, what the clinician verified vs. accepted).
The ethics committee question resurfaces here too — even though this is a methods paper rather than a case report, if it includes identifiable patient details from your 42F case, you'll likely still need either consent documentation or an ethics committee statement (many journals require this even for single-case methods papers that include clinical specifics). Worth checking this before drafting too far, since it affects how much of the worked example you can include.
Drafting approach — given the length and structure we've sketched (5 sections, worked example, limitations), this is a "build iteratively" document: outline first, then section by section. I can help draft this in a markdown file as we go, or you might want to start with just the abstract + Stage descriptions (sections 1-2) as a first pass to get the core framing right before fleshing out the worked example and discussion.
Here's a concise step-by-step guide reconstructing the workflow this user followed for analyzing their complex clinical case:
1. Extracted core terms from the case Started with a single complex case (42F with G6PD/AMPD1 deficiency, severe edema, etc.) and pulled out two clean lists: all diagnosis-related terms and all intervention-related terms mentioned in the case narrative.
2. Found comparable cases using those terms Used the extracted diagnosis/intervention keywords as search seeds to locate 5 similar cases online and on PubMed — essentially building a "comparison cohort" of patients with overlapping genetic/metabolic profiles or symptom clusters.
3. Aggregated and cross-compared Pulled the full case text from those 5 links into a single combined dataset ("one bucket"), then compared it against the original case to surface patterns, shared features, and points of divergence.
4. Supplied raw comparison data, requested two-tier analysis Provided the actual collected text of the 5 comparison cases as a file, then asked for insights at two levels:
Level 1: analysis based only on the original keyword extraction (diagnoses/interventions)
Level 2: analysis based on the full unstructured text of their own case
This separates a "structured/coded" view from a "narrative/contextual" view of the same case.
5. Asked for further analytic ideas Open-ended prompt — "anything more you suggest?" — to brainstorm additional analysis types beyond what had been done so far.
6. Selected a menu of advanced analytics Chose six specific deliverables to pursue:
Symptom → trigger → intervention timeline
Gene interaction network map
Intervention response scoring
Literature gap analysis document
Risk trajectory modeling
Lab value pattern analysis
7. Narrowed to final concrete outputs Converged on four specific, immediately actionable deliverables:
Severity rating per diagnosis
Priority rating per diagnosis
Condensed patient journey timeline
Intervention ↔ symptom relief correlation table
Overall pattern: the workflow moves from extraction → external benchmarking against similar cases → multi-level internal analysis → brainstorming advanced analytics → converging on a focused, decision-useful output set (severity/priority/timeline/correlation) — a fairly rigorous mini research pipeline for making sense of a single rare, multi-system case.
for this case of triple energy pathway deficit->
Based on this search and the earlier research, here's the honest answer:
"First of its kind" in the narrow sense — yes, very likely. I found no published case report, review, or framework that combines G6PD deficiency + AMPD1 deficiency + GSD type III/IX into a single "triple energy pathway" syndrome or diagnostic concept. Searching for this specific combination returns nothing — not even as a discussed hypothesis in rare-disease forums or case literature. So as a specific named framework applied to a specific patient, this appears genuinely novel.
But the underlying biochemistry is well-trodden — each piece individually is thoroughly studied. The searches confirm: G6PD deficiency's role in NADPH/glutathione/oxidative stress is extensively characterized, with decreased NADPH regeneration in the pentose phosphate pathway and subnormal levels of reduced glutathione resulting in insufficient antioxidant defense and increased susceptibility to oxidative stress. AMPD1's role in ATP regeneration during exertion is also well established, as the enzyme converts AMP into IMP during physical activity, which helps regenerate ATP to support sustained muscle contraction and recovery. GSD III/IX's role in glycogen mobilization is classic textbook metabolic biochemistry.
So the honest framing is: the bricks are all well-known; the specific wall built from them — three energy-pathway lesions converging on one patient's phenotype — doesn't appear to exist in the literature as a described entity. That's a meaningful distinction from "discovering new biochemistry." It's closer to a novel clinical synthesis — connecting three independently-documented rare conditions into one explanatory framework for a single patient's symptom pattern.
Why this matters for what it actually is:
It's the kind of insight that, if the GSD piece gets confirmed by biopsy, would genuinely be worth writing up as a case report — "tri-allelic energy metabolism disorder" type framing has precedent in rare disease literature (multiple-hit metabolic syndromes are a recognized category, just not this specific combination).
It's not "first of its kind" in the sense of discovering a new mechanism — it's "first of its kind" in the sense of nobody having put these three specific puzzle pieces together for this patient (or, as far as searchable literature shows, for any patient).
The caveat that matters most: GSD III/IX is still a VUS, unconfirmed. If biopsy doesn't support it, the "triple" framing collapses to "double" (G6PD + AMPD1), which — while still rare — is a less novel combination, though still not something with an existing combined case report based on this search.
Net: a real, apparently-original synthesis worth pursuing with a metabolic geneticist — but its ultimate status (publishable novel case vs. interesting-but-unconfirmed hypothesis) hinges entirely on that pending confirmation.
